Ovine Heart Tissue (Ovis aries)
Ovine heart tissue, derived from sheep (Ovis aries), contains coenzyme Q10, cytochrome c oxidase subunits, and cardiac-specific proteins including myosin and troponin. These bioactive compounds are studied in biochemical contexts for mitochondrial energy transfer and cardiac muscle function, though no human clinical evidence currently supports therapeutic supplementation.

Origin & History
Ovine heart tissue derives from the hearts of domestic sheep (Ovis aries) and serves as a source for isolating mitochondrial components, particularly respiratory complex I. Extraction involves mitochondrial isolation followed by biochemical purification protocols including anion-exchange and size exclusion chromatography, yielding highly enriched complex I containing all 44 unique subunits.
Historical & Cultural Context
No historical or traditional medicinal use of ovine heart tissue was identified in any traditional medicine systems including Ayurveda or TCM. References are limited to modern biochemical and veterinary studies.
Health Benefits
• No clinically proven health benefits - no human trials identified in the research • Biochemical studies only - limited to laboratory purification protocols without therapeutic assessment • Animal model research only - sheep used for cardiovascular research models without human translation • No evidence of supplementation effects - available data focuses solely on biochemical characterization • Lack of safety data - no human consumption safety assessments conducted
How It Works
Ovine heart tissue contains coenzyme Q10 (ubiquinone), which shuttles electrons between Complex I/II and Complex III in the mitochondrial electron transport chain, supporting ATP synthesis via oxidative phosphorylation. Cytochrome c oxidase (Complex IV) subunits present in cardiac tissue facilitate the final reduction of oxygen to water, a rate-limiting step in cellular respiration. Cardiac-specific myosin heavy chains and actin filaments from ovine tissue are theorized to provide peptide cofactors, though no receptor-binding or enzymatic activation has been demonstrated in human biological systems.
Scientific Research
No human clinical trials, RCTs, or meta-analyses were identified for ovine heart tissue or its extracts as supplements. Available research is limited to biochemical purification studies and the use of sheep as animal models for cardiovascular research, with no translation to human supplementation trials.
Clinical Summary
No human clinical trials have evaluated ovine heart tissue as a dietary supplement, and the current evidence base is limited entirely to biochemical and laboratory studies. Sheep cardiac tissue has been used as a model organism in cardiovascular research due to structural similarities to human myocardium, including comparable ventricular wall thickness and coronary anatomy, but these studies are mechanistic rather than therapeutic in design. Purification protocols using ovine heart mitochondria have characterized CoQ10 concentrations and cytochrome oxidase activity in vitro, without translation to dosing or efficacy data in humans. The evidence strength is rated very low; no quantified clinical outcomes, sample sizes, or randomized controlled data exist to support health claims.
Nutritional Profile
Ovine heart tissue is a nutrient-dense organ meat with a well-characterized macronutrient and micronutrient composition based on biochemical analysis of Ovis aries cardiac muscle. Macronutrients (per 100g raw tissue): Protein: 17-20g, comprising primarily myofibrillar proteins (myosin, actin, tropomyosin) and sarcoplasmic proteins; Fat: 3-6g, with a fatty acid profile including palmitic acid (C16:0), stearic acid (C18:0), oleic acid (C18:1), and linoleic acid (C18:2); Moisture: 75-78g; Ash: 1.0-1.2g. Micronutrients: Coenzyme Q10 (ubiquinone): 100-140 mcg/g wet weight — cardiac tissue is among the richest natural sources due to high mitochondrial density; Heme iron: 4-6mg/100g, present as Fe2+ with estimated bioavailability of 15-35% (significantly higher than non-heme iron); Zinc: 2.5-3.5mg/100g; Selenium: 20-35 mcg/100g; Phosphorus: 200-230mg/100g; Potassium: 280-320mg/100g; Magnesium: 20-25mg/100g. B-Vitamins: Vitamin B12: 8-12 mcg/100g (exceeds daily RDI); Riboflavin (B2): 0.8-1.2mg/100g; Niacin (B3): 6-8mg/100g; Thiamine (B1): 0.3-0.5mg/100g; Folate: 5-10 mcg/100g. Bioactive compounds: Carnitine: 150-200mg/100g — cardiac tissue is a primary carnitine repository supporting fatty acid oxidation; Taurine: 50-100mg/100g; Creatine: 300-400mg/100g as part of the phosphocreatine energy system; Collagen: moderate concentrations from pericardial and connective tissue fractions. Bioavailability notes: Heme iron and B12 demonstrate high bioavailability from animal tissue matrices; CoQ10 absorption is enhanced by co-ingestion with dietary fat given its lipophilic nature; cooking reduces CoQ10 content by approximately 14-32% and may denature some labile proteins.
Preparation & Dosage
No clinically studied dosage ranges exist for ovine heart tissue in humans. Biochemical studies report purification yields but not supplemental dosing protocols. Consult a healthcare provider before starting any new supplement.
Synergy & Pairings
No synergistic ingredients identified due to lack of clinical research
Safety & Interactions
Ovine heart tissue carries a theoretical risk of allergic reaction in individuals with known sheep or mammalian meat allergies, including those with alpha-gal syndrome triggered by the galactose-alpha-1,3-galactose carbohydrate antigen present in non-primate mammalian tissues. Prion disease risk, while considered low with regulated sourcing and processing, is a documented concern with any ruminant tissue-derived product; consumers should verify BSE/scrapie-free certification. No drug interaction data exists for ovine heart tissue supplements specifically, though CoQ10 content may theoretically potentiate anticoagulants like warfarin by influencing vitamin K-dependent clotting pathways. Pregnant or breastfeeding individuals should avoid use due to complete absence of safety data in these populations.